AXA S.A. - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 114 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
AXA S.A. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$1,666,000
-9.9%
562,773
-51.6%
0.01%
-12.5%
Q4 2018$1,849,000
-56.8%
1,162,6270.0%0.01%
-50.0%
Q3 2018$4,278,000
+30.0%
1,162,6270.0%0.02%
+23.1%
Q2 2018$3,290,000
-22.7%
1,162,627
+1.3%
0.01%
-23.5%
Q1 2018$4,258,000
+27.5%
1,147,834
-1.0%
0.02%
+30.8%
Q4 2017$3,340,000
-4.8%
1,159,555
+48.4%
0.01%
-13.3%
Q3 2017$3,508,000
-3.5%
781,356
-1.4%
0.02%
-11.8%
Q2 2017$3,636,000
+5.1%
792,206
-3.6%
0.02%
+6.2%
Q1 2017$3,458,000
-1.1%
821,413
-3.0%
0.02%0.0%
Q4 2016$3,497,000
-48.0%
846,611
+1.9%
0.02%
-46.7%
Q3 2016$6,727,000
-7.5%
830,520
-11.0%
0.03%
-6.2%
Q2 2016$7,276,000
-2.9%
932,784
-3.9%
0.03%
-5.9%
Q1 2016$7,496,000
-29.6%
970,957
-1.6%
0.03%
-27.7%
Q4 2015$10,646,000
+51.5%
986,643
-3.0%
0.05%
+62.1%
Q3 2015$7,029,000
+5.1%
1,017,206
+34.7%
0.03%
+7.4%
Q2 2015$6,689,000
-10.1%
755,0020.0%0.03%
-12.9%
Q1 2015$7,444,000
+52.8%
755,002
+89.8%
0.03%
+55.0%
Q4 2014$4,873,000
+5.1%
397,772
-14.4%
0.02%0.0%
Q3 2014$4,637,000
+382.5%
464,629
+295.3%
0.02%
+300.0%
Q2 2013$961,000117,5410.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders